Author:
Udwadia Zarir,Balsari Satchit,Ghafur Abdul
Reference5 articles.
1. Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India;Balsari;Lancet Infect Dis,2021
2. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial;Udwadia;Int J Infect Dis,2021
3. The efficacy and safetyof favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials;Hassanipour;Sci Rep,2021
4. Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19. A randomised clinical trial;Lopez-Medina;JAMA,2021
5. Ivermectin for preventing and treating COVID-19;Popp;Cochrane Database Syst Rev,2021